MTOR and renal carcinoma: In conclusion, PB28 binding to TMEM97 might inhibit phosphorylation of constituents of the PI3K‐AKT‐mTOR signalling pathway, resulting in decreased proliferation, migration and invasion of renal cancer in vitro and in vivo.